Skip to main content
Premium Trial:

Request an Annual Quote

Thermo Fisher, GenDx Ink Reseller Agreement for Ion Torrent in HLA Typing

NEW YORK (GenomeWeb) – GenDx announced today that it has signed a global reseller agreement, giving it the rights to offer Thermo Fisher Scientific's Ion Torrent next-generation sequencing systems and consumables as part of a human leukocyte antigen (HLA) typing workflow used in transplant diagnostics.

Under the terms of the agreement, Netherlands-based GenDx and its distributors can provide the Ion PGM, S5, and Chef systems to customers alongside GenDx's HLA-NGSgo reagents and NGSengine software.

In recent years, NGS-based HLA typing has started to gain momentum, with Illumina and CareDx making deals in the space. GenDx has acquired CE-IVD marking for its HLA typing workflow for the Illumina MiSeq, NGSengine software product, and for its Sanger sequencing-based workflow. The firm said in a statement that it has begun the process of getting the CE mark for NGSgo on the Ion Torrent platform.

"We have evaluated the HLA typing results with the NGSgo full workflow strategies on multiple NGS platforms," GenDx CEO Wietse Mulder said in a statement. "The Ion PGM and Ion S5 systems provide reliable typing results that are of high resolution and phasing comparable to other NGS platforms on the market."

Financial and other terms of the agreement were not disclosed.

The Scan

US Booster Eligibility Decision

The US CDC director recommends that people at high risk of developing COVID-19 due to their jobs also be eligible for COVID-19 boosters, in addition to those 65 years old and older or with underlying medical conditions.

Arizona Bill Before Judge

The Arizona Daily Star reports that a judge weighing whether a new Arizona law restricting abortion due to genetic conditions is a ban or a restriction.

Additional Genes

Wales is rolling out new genetic testing service for cancer patients, according to BBC News.

Science Papers Examine State of Human Genomic Research, Single-Cell Protein Quantification

In Science this week: a number of editorials and policy reports discuss advances in human genomic research, and more.